Fortis Healthcare Limited is one of India’s leading integrated healthcare service providers, offering world-class medical care across a wide range of specialties. Known for its advanced medical technology, experienced healthcare professionals, and patient-first approach, Fortis has become synonymous with quality healthcare. With a strong network of hospitals, Fortis caters to patients both in India and internationally, playing a pivotal role in transforming the healthcare landscape. As of December, 06, 2024, the Fortis Healthcare share price on the NSE is ₹714. Below are the projected Fortis Healthcare share price target for the years 2024, 2025, 2026, 2027, 2030, 2035 And 2040.
Additionally, feel free to join our – Tele-(g)ram) where we share Fast stock market news and updates➥https://bit.ly/TradeWatch360
Fortis Healthcare Company Overview
Founded in 2001 and headquartered in Gurugram, Haryana, Fortis Healthcare operates a vast network of multi-specialty hospitals, diagnostics centers, and day-care facilities across India and internationally. The company provides comprehensive medical services in specialties such as cardiology, oncology, orthopedics, neurology, gastroenterology, and critical care. Fortis Healthcare is recognized for its cutting-edge medical infrastructure and a team of highly skilled doctors, nurses, and technicians. Its flagship hospitals, including Fortis Memorial Research Institute (FMRI) in Gurugram and Fortis Escorts Heart Institute in Delhi, are known for excellence in clinical care and research.
| Company type | Public |
| Traded as | BSE: 532843 NSE: FORTIS |
| Industry | Healthcare |
| Founded | 1996; 28 years ago |
| Headquarters | Gurgaon, India |
| Area served | Worldwide |
| Key people | Ravi Rajagopal (Chairman) |
| Products | Hospitals Pharmacy Diagnostic Centres |
| Revenue | ₹7,313 crore(US$760 million) (2023) |
| Operating income | ₹1442 crore(US$110 million) (2023) |
| Net income | ₹704 crore(US$73 million) (2023) |
| Number of employees | 24,000 (2024) |
| Parent | IHH Healthcare (31.1%) |
| Website | www.fortishealthcare.com |
Fortis Healthcare Share Price Target 2025-2040 Forecast
| Year | Year High Target (₹) | Year Low Target (₹) | Year-End Target (₹) |
| 2024 | 760 | 370 | 730 |
| 2025 | 910 | 570 | 880 |
| 2026 | 1170 | 750 | 1040 |
| 2027 | 1450 | 940 | 1320 |
| 2028 | 1800 | 1150 | 1670 |
| 2029 | 2250 | 1400 | 2040 |
| 2030 | 2770 | 1830 | 2550 |
| 2035 | 5240 | 2250 | 4900 |
| 2040 | 8050 | 4650 | 7800 |
Technical Analysis for Fortis Healthcare
Fortis Healthcare Share Price Target 2025
| Year | 1st Target | 2nd Target |
| 2025 | 850 | 910 |
The healthcare sector is poised for growth, with Fortis Healthcare focusing on expansion and service excellence. The share price is projected to reach ₹850 for the first target and ₹910 for the second target in 2025.
Read More:- Apollo Share Price Target 2025, 2030, 2035, 2040
Fortis Healthcare Share Price Target 2026
| Year | 1st Target | 2nd Target |
| 2026 | 1050 | 1170 |
In 2026, with continuous improvements in healthcare infrastructure and Fortis’ leadership in the private hospital sector, the share price is expected to hit ₹1050 for the first target and ₹1170 for the second target.
Fortis Healthcare Share Price Target 2027
| Year | 1st Target | 2nd Target |
| 2027 | 1300 | 1450 |
By 2027, driven by strategic investments and patient-centric services, Fortis Healthcare share price is anticipated to touch ₹1300 for the first target and ₹1450 for the second target.
Fortis Healthcare Share Price Target 2028
| Year | 1st Target | 2nd Target |
| 2028 | 1640 | 1800 |
In 2028, Fortis is expected to benefit from a growing demand for quality healthcare services. The share price is forecasted to reach ₹1640 for the first target and ₹1800 for the second target.
Fortis Healthcare Share Price Target 2029
| Year | 1st Target | 2nd Target |
| 2029 | 2010 | 2250 |
As healthcare spending increases and Fortis expands its operations, the share price is projected to climb to ₹2010 for the first target and ₹2250 for the second target by 2029.
Fortis Healthcare Share Price Target 2030
| Year | 1st Target | 2nd Target |
| 2030 | 2400 | 2770 |
By 2030, leveraging its strong brand reputation and increasing market penetration, Fortis Healthcare’s share price is estimated to hit ₹2400 for the first target and ₹2770 for the second target.
Fortis Healthcare Share Price Target 2035
| Year | 1st Target | 2nd Target |
| 2035 | 3900 | 5240 |
In the longer term, with robust demand for private healthcare services and enhanced profitability, the share price is expected to rise to ₹3900 for the first target and ₹5240 for the second target by 2035.
Read More:- Niva Bupa Share Price Target 2025, 2030, 2035, 2040
Fortis Healthcare Share Price Target 2040
| Year | 1st Target | 2nd Target |
| 2040 | 7400 | 8050 |
By 2040, Fortis Healthcare is anticipated to solidify its position as a leading healthcare provider in India. The share price is projected to reach ₹7400 for the first target and ₹8050 for the second target, reflecting its long-term growth trajectory.
Fortis Healthcare Ltd Fundamentals
| Parameter | Value |
| Market Cap | ₹53,630Cr |
| P/E Ratio (TTM) | 81.81 |
| P/B Ratio | 6.84 |
| Industry P/E | 72.44 |
| Debt to Equity | 0.15 |
| ROE | 8.36% |
| EPS (TTM) | 8.69 |
| Dividend Yield | 0.14% |
| 52 Week High | ₹370 |
| 52 Week Low | ₹740 |
| Book Value | 103.94 |
| Face Value | 10 |
Fortis Healthcare Ltd Financial Results
| All in ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
| Sales | 4,030 | 5,718 | 6,298 | 6,893 | 7,313 |
| Expenses | 3,626 | 4,649 | 5,196 | 5,625 | 5,870 |
| Operating Profit | 404 | 1,069 | 1,101 | 1,268 | 1,442 |
| OPM % | 10% | 19% | 17% | 18% | 20% |
| Other Income | 95 | 367 | 157 | 64 | 8 |
| Interest | 166 | 147 | 129 | 131 | 139 |
| Depreciation | 291 | 301 | 316 | 342 | 365 |
| Profit before tax | 43 | 988 | 814 | 858 | 946 |
| Tax % | 230% | 20% | 22% | 25% | |
| Net Profit | -56 | 790 | 633 | 645 | 704 |
| EPS in Rs | -1.45 | 7.35 | 7.80 | 7.93 | 8.69 |
| Dividend Payout % | 0% | 0% | 13% | 13% |
Fortis Healthcare Balance Sheet
| All in ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
| Equity Capital | 755 | 755 | 755 | 755 | 755 |
| Reserves | 5,365 | 5,423 | 6,487 | 6,908 | 7,092 |
| Borrowings | 1,531 | 1,255 | 926 | 1,155 | 1,186 |
| Other Liabilities | 3,216 | 4,082 | 3,921 | 4,153 | 4,563 |
| Total Liabilities | 10,866 | 11,516 | 12,089 | 12,971 | 13,597 |
| Fixed Assets | 8,799 | 9,416 | 9,426 | 9,874 | 10,172 |
| CWIP | 165 | 193 | 228 | 542 | 435 |
| Investments | 186 | 104 | 210 | 230 | 175 |
| Other Assets | 1,716 | 1,803 | 2,225 | 2,326 | 2,814 |
| Total Assets | 10,866 | 11,516 | 12,089 | 12,971 | 13,597 |
Fortis Healthcare Ltd Shareholding Pattern
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
| Promoters | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% |
| FIIs | 34.42% | 29.82% | 31.22% | 23.24% | 25.26% |
| DIIs | 13.57% | 16.90% | 20.69% | 31.14% | 30.73% |
| Public | 20.84% | 22.12% | 16.92% | 14.44% | 12.83% |
| No. of Shareholder | 1,09,889 | 1,56,881 | 1,37,894 | 1,57,165 | 2,04,184 |
Fortis Healthcare Dividend History
| Announcement Date | Ex-Dividend Date | Dividend Type | Dividend (Rs) |
| 24 May, 2023 | 20 Jul, 2023 | Final | 1.00 |
| 23 May, 2024 | – | Final | 1.00 |
Fortis Healthcare Peers comparison
| Sector: Healthcare | |||||
| Name | P/E | Mar Cap ₹Cr. | Div Yld% | NP Qtr ₹Cr. | ROCE% |
| Max Healthcare | 99.60 | 105466 | 0.14 | 281.81 | 16.00 |
| Apollo Hospitals | 88.07 | 104100 | 0.22 | 395.70 | 15.11 |
| Fortis Health. | 76.15 | 52348 | 0.14 | 193.08 | 10.34 |
| Fortis Healthcare | 63.50 | 30985 | 0.00 | 130.81 | 19.32 |
| Poly Medicure | 100.57 | 29642 | 0.10 | 87.45 | 23.62 |
| Narayana Hrudaya | 34.28 | 26738 | 0.31 | 198.80 | 26.54 |
| Dr Lal Pathlabs | 62.26 | 24990 | 0.81 | 130.80 | 25.17 |
FAQs
Q1: Fortis Healthcare Share Price Target 2025?
Ans: The projected share price targets for 2025 are ₹850 (1st target) and ₹910 (2nd target), reflecting steady growth due to the rising demand for healthcare services.
Q2: Fortis Healthcare Share Price Target 2026?
Ans: In 2026, the share price is expected to reach ₹1050 (1st target) and ₹1170 (2nd target), supported by Fortis’ expanding footprint in healthcare services and innovative medical offerings.
Q3: Fortis Healthcare Share Price Target 2027?
Ans: The expected share price for 2027 is ₹1300 (1st target) and ₹1450 (2nd target), fueled by growth in healthcare infrastructure and patient volume.
Q4: Fortis Healthcare Share Price Target 2028?
Ans: The expected share price for 2027 is ₹1300 (1st target) and ₹1450 (2nd target), fueled by growth in healthcare infrastructure and patient volume.
Q5: Fortis Healthcare Share Price Target 2029?
Ans: In 2029, the share price is projected to achieve ₹2010 (1st target) and ₹2250 (2nd target), reflecting Fortis’ dominance in the private healthcare sector.
Q6: Fortis Healthcare Share Price Target 2030?
Ans: The share price for 2030 is expected to touch ₹2400 (1st target) and ₹2770 (2nd target), supported by strong revenue growth and increasing investments in premium healthcare facilities.
Q7: Fortis Healthcare Share Price Target 2035?
Ans: By 2035, the price is expected to climb to ₹3900 (1st target) and ₹5240 (2nd target), benefiting from long-term demand for quality healthcare and Fortis’ leadership position.
Q8: Fortis Healthcare Share Price Target 2040?
Ans: The share price target for 2040 is projected to reach ₹7400 (1st target) and ₹8050 (2nd target), reflecting the company’s strategic expansion and robust financial performance.
Q9: What is the NSE and BSE code for Fortis Healthcare Ltd?
Ans: Fortis Healthcare is listed on both the NSE and BSE.
NSE Code: FORTIS
BSE Code: 532843
Q10: Who is the CEO of Fortis Healthcare?
Ans: The current CEO of Fortis Healthcare is Dr. Ashutosh Raghuvanshi. He has been leading the company since March 2019. Dr. Raghuvanshi has a rich background in the healthcare sector, having previously worked with the Narayana Hrudayalaya Group for over 18 years, where he served as the Group CEO and Managing Director.
TradeWatch360 is a premier platform dedicated to providing real-time insights, trends, and updates in the stock market. It is designed to support both new and seasoned investors by delivering timely and actionable information across a range of asset classes, including stocks, futures, commodities, and global markets.